Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen

Abstract

MN-14 is being evaluated for radioimmunodetection of and radioimmunotherapy for CEA-containing cancers, whereas MN-3 is being studied for the radioimmunodetection of occult infections and sites of inflammation.